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Purpose:

To quantitatively compare hyperpolarized helium 3 (3He)
and xenon 129 (129Xe) magnetic resonance (MR) images
obtained within 5 minutes in healthy volunteers and patients with chronic obstructive pulmonary disease (COPD)
and to evaluate the correlations between 3He and 129Xe
MR imaging measurements and those from spirometry and
plethysmography.

Materials and
Methods:

This study was approved by an ethics board and compliant with HIPAA. Written informed consent was obtained
from all subjects. Eight healthy volunteers and 10 patients
with COPD underwent MR imaging, spirometry, and plethysmography. Ventilation defect percentages (VDPs) at 3He
and 129Xe imaging were obtained by using semiautomated
segmentation. Apparent diffusion coefficients (ADCs) were
calculated from 3He (b = 1.6 sec/cm2) and 129Xe (b = 12
sec/cm2) diffusion-weighted images. VDPs at hyperpolarized
3
He and 129Xe imaging were compared with a two-tailed Wilcoxon signed rank test and analysis of variance; Pearson correlation coefficients were used to evaluate the relationships
among measurements.

Results:

129
Xe VDP was significantly greater than 3He VDP for patients
with COPD (P , .0001) but not for healthy volunteers (P =
.35), although 3He and 129Xe VDPs showed a significant correlation for all subjects (r = 0.91, P , .0001). The forced expiratory
volume in 1 second (FEV1) showed a similar and significant
correlation with 3He VDP (r = 20.84, P , .0001) and 129Xe
VDP (r = 20.89, P , .0001), although the correlation between
the FEV1/forced vital capacity (FVC) ratio and 129Xe VDP (r =
20.95, P , .0001) was significantly greater (P = .01) than that
for FEV1/FVC and 3He VDP (r = 20.84, P , .0001). A significant correlation was also observed for 3He and 129Xe ADC (r =
0.97, P , .0001); 129Xe ADC was significantly correlated with
diffusing capacity of lung for carbon monoxide (r = 20.79, P
= .03) and computed tomographic emphysema measurements
(areas with attenuation values in the 15th percentile: r = 20.91,
P = .0003; relative areas with attenuation values of less than
2950 HU: r = 0.87, P = .001).

Conclusion:

In patients with COPD, the VDP obtained with hyperpolarized
29
Xe MR imaging was significantly greater than that with 3He
MR imaging, suggesting incomplete or delayed filling of lung
regions that may be related to the different properties of 129Xe
gas and physiologic and/or anatomic abnormalities in COPD.
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M

agnetic resonance (MR) imaging
with use of hyperpolarized noble
gases such as helium 3 (3He) and
xenon 129 (129Xe) provides a way to acquire high spatial and temporal resolution

Advances in Knowledge
nn For healthy volunteers and
patients with COPD who underwent both helium 3 (3He) and
xenon 129 (129Xe) MR imaging
within approximately 5 minutes,
there were significant and strong
correlations between 129Xe and
3
He ventilation defect percentages (VDPs) (r = 0.91, P ,
.0001); however, for patients
with COPD, the VDP with 129Xe
MR imaging was significantly
greater than that with 3He MR
imaging (P , .0001).
nn There was a similar and strong
correlation between VDPs
obtained with 129Xe and 3He imaging and forced expiratory
volume in 1 second (FEV1), but
the relationship between 129Xe
imaging–derived VDP and the
FEV1/forced vital capacity ratio
(r = 2.95, P , .0001) was significantly stronger than that for 3He
imaging–derived VDP (P = .01).
nn There were also significant and
strong correlations between apparent diffusion coefficients
(ADCs) obtained with 3He and
those obtained with 129Xe (r =
.97, P , .0001), and both measurements were significantly different in healthy subjects and
patients with COPD (P , .001).
nn In all subjects, 129Xe imaging–
derived ADC was significantly
correlated with diffusing capacity
of lung for carbon monoxide (r =
2.93, P , .0001); for patients
with COPD, there were significant correlations with CT measurements of emphysema (areas
with attenuation values in the
15th percentile: r = 2.91, P =
.0003; relative areas with attenuation values of less than 2950
HU: r = .87, P = .001).
Radiology: Volume 265: Number 2—November 2012
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pulmonary images (1–4). Hyperpolarized
He MR imaging has dominated for the
evaluation of gas distribution and tissue
abnormalities in healthy volunteers (5);
patients with chronic obstructive pulmonary disease (COPD) (6–9), asthma
(10–14), cystic fibrosis (15–18), and
radiation-induced lung injury (19,20);
and lung transplant recipients (21,22).
Numerous studies have shown that 3He
MR imaging in COPD is highly reproducible (6,23–25), is sensitive to early lung
microstructural changes (1,26–31), and
shows significant correlation with established measurements of pulmonary function (1,32)—multisection computed tomography (CT) measurements (32) and
histologic measurements of emphysema
(33). Furthermore, longitudinal 3He MR
imaging of COPD has highlighted the
sensitivity of the method to progressive
worsening (8,34) and shown regional
improvements after bronchodilator use
(35,36).
Unfortunately, despite the unique
potential of 3He MR imaging, clinical
translation has not occurred in part
because of limited and unpredictable
global quantities and high cost. 129Xe
gas, conversely, is substantially more
abundant in nature, existing in measurable quantities in the atmosphere,
and is relatively inexpensive. Although
hyperpolarized 129Xe MR imaging is
technically challenging because of its
nearly threefold lower gyromagnetic ratio and lower enrichment, considerable
improvements in 129Xe gas polarization
and imaging methods (37) have been
achieved since the first clinical studies
were reported (38–40). Recently, the
tolerability of a 1.0-L inhaled dose of
129
Xe and diffusion-weighted MR imaging measurements were reported in patients with COPD and healthy subjects
3

Implication for Patient Care
nn Differences between VDPs
obtained at 129Xe and 3He MR
imaging in COPD may reflect differences in the properties of the
gases and physiologic and/or anatomic abnormalities in COPD
that are not seen in healthy
volunteers.

radiology.rsna.org
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(39,40). These important results suggested that 129Xe MR imaging may be
very useful for examining structural
and functional abnormalities in COPD
and generated numerous hypotheses to
test. In this investigation, we hypothesized that the different properties of
129
Xe gas would result in significant
differences in the ventilation defect
percentage (VDP) obtained with 129Xe
compared with 3He in patients with
COPD but not in healthy volunteers.
Accordingly, our objective was to quantitatively compare hyperpolarized 3He
and 129Xe MR images obtained within
5 minutes in healthy volunteers and patients with COPD and to evaluate the
correlations between 3He and 129Xe MR
imaging measurements and those from
spirometry and plethysmography.

Materials and Methods
Subjects
All subjects provided written informed
consent to the study protocol, which
was approved by the local research
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ADC = apparent diffusion coefficient
COPD = chronic obstructive pulmonary disease
DLCO = diffusing capacity of lung for carbon monoxide
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SNR = signal-to-noise ratio
3D = three-dimensional
2D = two-dimensional
VDP = ventilation defect percentage
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ethics board and Health Canada, and
the study was compliant with the Personal Information Protection and Electronic Documents Act of Canada and
the Health Insurance Portability and
Accountability Act of the United States.
Patients with COPD ranged in age from
50 to 85 years and were ex-smokers
with a smoking history of at least 10
pack-years. A pack-year was defined as
the number of cigarette packs smoked
per day multiplied by the number of
years smoked. Healthy volunteers
were enrolled if they had no history of
chronic or current respiratory disease.
The mean age of all subjects (6standard deviation) was 71 years 6 8. Men
had a mean age of 71 years 6 9, and
women had a mean age of 72 years 6 6.

Pulmonary Function Tests
Spirometry was performed by using an
EasyOne spirometer (ndd Medizintechnik, Zurich, Switzerland) according to
American Thoracic Society guidelines
(41). Static lung volumes and diffusing
capacity of lung for carbon monoxide
(DLCO) were measured by using body
plethysmography (MedGraphics, St
Paul, Minn).
Image Acquisition
MR imaging was performed with a
whole-body 3.0-T unit (Discovery
750MR; GE Healthcare, Milwaukee,
Wis) with broadband imaging capability, as previously described (6). Subjects were instructed to inhale a gas
mixture from a 1.0-L Tedlar bag (Jensen Inert Products, Coral Springs, Fla)
from functional residual capacity, and
image acquisition was performed in
8–15 seconds under breath-hold conditions. It is important to note that we endeavored to minimize the potential for
differences in the levels of inspiration
between the breath-hold images for
each subject by (a) conducting training
and practice sessions for all subjects
before MR imaging related to the inspiration breath-hold maneuver from
functional residual capacity and (b)
continuous coaching and monitoring at
the MR imaging table by a pulmonary
function technologist during all inspiration breath-hold acquisitions.
602
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Conventional hydrogen 1 (1H) MR
imaging was performed before hyperpolarized 129Xe and 3He MR imaging,
with subjects imaged during 1.0-L
breath hold of ultra–high purity medical
grade nitrogen 2 (N2) (Spectra Gases,
Alpha, NJ) by using a whole-body radiofrequency coil and a 1H fast spoiled
gradient-recalled echo sequence as previously described (6). Theoretical diffusion coefficients for the 3He-N2 and
129
Xe-4He 50/50 mixtures were generated, adopting assumptions previously
described (Appendix E1 [online]) (42).
Hyperpolarized 3He MR imaging
was enabled by using a linear birdcage
transmit-receive chest coil (Rapid Biomedical, Wuerzburg, Germany). A
turnkey system (HeliSpin, GE Healthcare) was used to polarize 3He gas to
30%–40%, and doses of 5 mL per kilogram of body weight, diluted with N2,
were administered in 1.0-L Tedlar bags.
Hyperpolarized coronal static ventilation 3He MR images and diffusionweighted (DW) images were acquired
during breath hold of a 1.0-L 3He-N2
mixture as previously described (6).
Hyperpolarized 129Xe MR imaging
was enabled by using a custom-made,
unshielded quadrature-asymmetric birdcage coil model tuned to 35.34 MHz,
similar to previous approaches (43) and
as previously described (44). 129Xe gas
(86% enriched) was polarized to 10%–
60% by using a turnkey polarizer system
(XeBox-E10; Xemed, Durham, NH).
Doses of hyperpolarized 129Xe gas were
dispensed directly into the prerinsed 1.0L Tedlar bags prefilled with 4He to generate a 50/50 mixture. Polarization of the
diluted dose was quantified with use of
a Polarimeter (GE Healthcare, Durham,
NC). Coronal static ventilation images
were acquired by using a three-dimensional (3D) fast gradient-recalled echo
sequence with centric phase-encoding
ordering in the y direction and normal
sampling in the z direction during breath
hold of the 1.0-L 129Xe-4He mixture
(data acquisition time = 14 seconds,
repetition time msec/echo time msec =
6.7/1.50, variable flip angle, 15.63-kHz
bandwidth, 40 3 40-cm field of view,
128 3 128 matrix, 14 sections, 15-mmthick sections, no gap). DW images were

obtained by using a two-dimensional (2D)
fast gradient-recalled echo sequence with
centric phase-encoding ordering. Two interleaved images (total data acquisition
time = 16 seconds, 13.5/10, 9° flip angle,
31.25-kHz bandwidth, 40 3 40-cm field
of view, 128 3 80 matrix, seven sections;
30-mm-thick sections, no gap), with and
without additional diffusion sensitization
with b = 12 sec/cm2 (maximum gradient
amplitude = 2.90 G/cm, gradient rise and
fall time = 0.5 msec, gradient separation
= 2 msec, gradient duration = 2.0 msec,
diffusion time = 5 msec). The diffusion
time of 5 msec for 129Xe MR imaging
was selected on the basis of the theoretical background for optimal gradient
sequence parameters (45) and previous
findings demonstrating its sensitivity to
alveolar enlargement (46). All imaging
was completed within approximately 5
minutes of subjects first lying in the MR
unit. In addition, based on the calculations for the theoretical diffusion coefficients for 3He and 129Xe and the diffusion
times used, the characteristic diffusion
length for 3He (~490 mm) is comparable
to that for 129Xe (~460 mm), indicating
that similar spatial length scales are being
investigated.
Computed tomography (CT) was
performed with a 64-section unit
(Lightspeed VCT; GE Healthcare, Milwaukee, Wis) by using a detector configuration of 64 3 0.625 mm, 120 kVp,
effective tube current of 100 mA, tube
rotation time of 500 msec, and pitch of
1.0. A single spiral acquisition of the
entire lung was acquired from the apex
to the base with subjects in the supine
position and with breath holding after
inhalation of a 1.0-L Tedlar bag of N2
from functional residual capacity. Reconstruction of the data was performed
by using a section thickness of 1.25 mm
with a standard convolution kernel.

Image Analysis
Semiautomated segmentation of 3He
and 129Xe MR images was performed,
similar to approaches that have been
previously described for quantification
of lung volumes (47), by using custom software generated with Matlab
R2007b (Mathworks, Natick, Mass),
as previously described (48). 3He MR

radiology.rsna.org
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imaging of COPD is typically characterized by heterogeneous signal intensity
that reflects gas distribution heterogeneity during inspiration breath-hold
imaging. To compare the distribution
of both 3He and 129Xe gases within the
lung, we segmented the 3He and 129Xe
images on the basis of pixel signal intensity. Briefly, 3He and 129Xe static
ventilation MR images were segmented
by using a k-means approach (49) in
which voxel intensity values are classified into five clusters ranging from signal void (cluster 1 or ventilation defect
volume) and hypointense signal (cluster
2 or partial volume) to hyperintense
signal (cluster 5), therefore generating a gas distribution cluster map. For
delineation of the ventilation defect
boundaries, a seeded region-growing
algorithm (50) was used to segment the
1
H MR images of the thoracic cavity for
registration to the cluster map and 3He
and 129Xe VDPs (7) were generated by
using ventilation defect volume normalized to the thoracic cavity volume. 3He
and 129Xe non-DW images were also
segmented by using the same approach,
where non-DW images were segmented
by using k-means cluster analysis and
registered to the corresponding 1H MR
imaging sections to calculate VDP (49).
Apparent diffusion coefficient (ADC)
analysis was performed as previously
described (36). The signal-to-noise ratio (SNR) for all 3He and 129Xe static
ventilation and non-DW and DW images was determined by calculating the
mean voxel value within a 5 3 5-cm2
voxel region of interest (ROI) for four
representative ROIs within the lung parenchyma and dividing it by the standard deviation of the voxel values for
noise inside four representative ROIs
of the same size within the image
background, where there was no lung
structure. The ROIs within the lung parenchyma and the image background
were selected independently for each
section, with the exception of DW imaging, where the ROIs were selected
independently for each non-DW image
section, and the coordinates of the lung
ROI were applied to the DW image section. The SNR was determined for each
section and then averaged to obtain a
Radiology: Volume 265: Number 2—November 2012
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single SNR value for each subject. CT
measurements were performed by using Matlab R2007b; the relative areas
with attenuation values of less than
2950 HU and areas with attenuation
values in the 15th percentile were generated from the frequency distribution
of Hounsfield units.

Statistical Methods
Multivariate analysis of variance and
one-way analysis of variance were performed with software (IBM SPSS Statistics 20.0; SPSS, Chicago, Ill). A paired
two-tailed t test was used for statistical
comparison for normally distributed
data, and a two-tailed Wilcoxon signed
rank test was used for statistical comparison for nonnormally distributed
data for tests between 3He and 129Xe
VDP, ADC, and SNR by using software
(Prism, version 4.00; GraphPad Software, San Diego, Calif). Normality was
determined with a Shapiro-Wilk test by
using IBM SPSS Statistics 20.0. Twoway mixed-effects repeated measures
analysis of variance was used to determine the interactions for VDP measured at both 3He and 129Xe MR imaging and imaging section by using IBM
SPSS Statistics 20.0. The agreement
between VDP measurements obtained
at 3He and 129Xe imaging was evaluated
with Bland-Altman plots (51) generated
by GraphPad software (Prism, version
4.00). Linear regression (r2 values)
and Pearson correlation coefficients
(r values) were used to determine the
relationships between imaging and
other measurements by using software
(Prism, version 4.00). Correlation coefficients were compared (52) by calculating the Fisher z9 transformation for
each r value, as follows:
=
z′

1
[log(1 + r ) − log(1 − r )],
2

where r is the correlation coefficient for
3
He or 29Xe MR imaging (rHe and rXe,
respectively). The Z value was then calculated as follows:

radiology.rsna.org

Z =

z He − z Xe
,
1
n−3

where ZHe is the z9 of rHe, ZXe the z9 of
rXe, and n the number of subjects compared. A Holm-Bonferroni correction
(53) was used for multiple paired t
tests and all correlations. The HolmBonferroni–adjusted P values were
determined by ordering P values from
smallest to largest, with the smallest P
value multiplied by k, where k is the
number of hypotheses to be tested. If
the resulting modified P value was less
than a (type I error rate), the hypothesis was rejected. The next smallest
P value was then multiplied by k 2 1
and the new modified P value compared
with a. This process was repeated until
the modified P value could not be rejected. In all statistical analyses, results
were considered significant when the
probability of making a type I error was
less than 5% (P , .05).

Results
All imaging procedures and maneuvers
were well tolerated, and no serious
or severe adverse events were reported. There was a single adverse event
reported by one patient with COPD
(headache 7 hours after completion
of MR imaging that resolved without
treatment), and this was judged to be
unrelated to 3He or 129Xe gas inhalation; the details of the safety and tolerability of 129Xe MR imaging for this
study are reported elsewhere (54), and
the tolerability of a 1.0-L 129Xe dose (vs
the 50/50 mixture used herein) was
previously reported (40). Table 1 shows
demographic characteristics and pulmonary function measurements for the
eight healthy volunteers and 10 patients
with COPD. One patient had Global
Initiative for Chronic Obstructive Lung
Disease (GOLD) class I, six patients
had GOLD class II, two patients had
GOLD class III, and one patient had
GOLD class IV (55). The two subject
groups were significantly different with
respect to FEV1, FEV1/FVC ratio, reserve volume, ratio of reserve volume
to total lung capacity, inspiratory capacity, functional residual capacity, and
DLCO; there were no significant differences between the groups with respect
to age, sex, or body mass index.
603
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Figure 1 shows coronal 3He and
Xe MR images for the two central
sections, where the trachea and two
main bronchi are clearly visible, with
3
He gas distribution displayed in red
and 129Xe gas distribution displayed in
purple. The 3He and 129Xe MR images
are registered to the gray-scale 1H MR
images of the thorax for three representative healthy volunteers and three
patients with COPD. For patients with
COPD, regions of signal void are observed on 129Xe MR images but are not
qualitatively apparent on 3He MR images; these regions are readily observed
in the right mid-apical region in one
volunteer and in the right and left apical regions in the other two volunteers.
Figure 2 shows the strong and statistically significant correlations between whole-lung 3He and 129Xe VDP (r
= 0.91, P , .0001) and 3He and 129Xe
ADC (r = 0.97, P , .0001). Although
VDPs at 3He and 129Xe imaging showed
significant correlation, Bland-Altman
analysis indicates that there was a 9%
6 8 bias (95% limit of agreement:
225% to 7%) for higher VDP for 129Xe
MR imaging. Table 2 shows mean gas
distribution and ADC measurements
for 3He and 129Xe MR imaging. The
VDP obtained with 129Xe imaging was
significantly greater than that with 3He
imaging for the patients with COPD (P
= .0003, uncorrected; P = .03, HolmBonferroni corrected), and 129Xe signal intensity cluster 3 was significantly
different (P = .002, uncorrected; P =
.002, Holm-Bonferroni corrected). For
healthy volunteers, there was no significant difference between 129Xe VDP and
3
He VDP (P = .56); however, there was
a significant difference in cluster 4 (P
= .008, uncorrected). With Holm-Bonferroni correction, however, this difference was no longer significant (P = .06).
For both groups, there was no relationship between the difference in 3He and
129
Xe VDPs and image section (P =
.99), indicating no bias for differences
between 3He and 129Xe VDP for any
specific image section. To better understand the potential effect of any difference in pulse sequence parameters for
129
Xe (3D acquisition) and 3He (2D acquisition) MR imaging gas distribution
129
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Table 1
Summary of Demographics
Parameter*
Mean age (y)
Men
Women
No. of men
BMI (kg/m2)
Pack-years
FEV1‡
FVC‡
FEV1/FVC
TLC‡
RV‡
RV/TLC‡
IC‡
FRC‡
DLCO‡

Healthy Volunteers (n = 8)

Patients with COPD (n = 10)

P Value†

67 (10)
63 (11)
71 (7)

74 (4)
75 (4)
73 (6)

.10

4
25.9 (2.2)
0 (0)
107 (13)
106 (13)
0.75 (0.04)
106 (11)
105 (19)
0.39 (0.10)
120 (25)
95 (13)
103 (13)

8
25.4 (5.0)
62 (15)
57 (24)
91 (19)
0.46 (0.14)
115 (8)
159 (46)
0.53 (0.14)
85 (31)
141 (35)
41 (17)§

.32
.79
NA
,.001
.08
,.0001
.09
.007
.03
.02
.002
,.0001

Note.—Numbers in parentheses are standard deviations.
* BMI = body mass index, FRC = functional residual capacity, IC = inspiratory capacity, RV = reserve volume, TLC = total lung
capacity.
†
Significant difference between groups (P , .05) was determined by using multivariate analysis of variance. The Fisher exact
test was performed for categorical variables. NA = not applicable.
‡

Data are percentage predicted values.

§

Available for seven patients.

measurements, we compared 3He and
Xe VDPs measured from non-DW
images acquired with 2D fast gradientrecalled echo sequences. No significant
difference was observed between 129Xe
VDPs obtained with 3D acquisition and
those measured from non-DW images
for the healthy volunteers and patients
with COPD (P = .87). 3He VDPs obtained with 2D acquisition were not
significantly different from those measured from non-DW images for healthy
volunteers (P = .50); however, they
were significantly different for patients
with COPD (P = .002). This result is
in agreement with the 2D 3He and 3D
129
Xe MR imaging results that showed
there was no difference between 3He
and 129Xe VDPs for healthy volunteers
but that 129Xe VDP was significantly
greater than 3He VDP for patients with
COPD. Mean SNR was significantly
lower for 129Xe MR imaging (33 6 17)
than for 3He MR imaging (56 6 25) (P
, .0001); however, importantly, there
was no significant correlation for the
difference between 3He and 129Xe SNR
129

and the difference between 3He and
129
Xe VDP (r = 0.26, P = .30).
As shown in Table 2, whole lung
hyperpolarized 3He and 129Xe ADC was
significantly different for the healthy
volunteers (P = .002) and the patients
with COPD (P , .0001). The mean
SNRs were 36 6 16 and 64 6 29 for
DW and non-DW 3He MR imaging, respectively, and 11 6 6 and 28 6 19 for
DW and non-DW 129Xe MR imaging.
Table 3 shows Pearson correlations
between 3He and 129Xe VDP and ADC
and pulmonary function measurements.
There were significant and similar correlations for 3He and 129Xe MR imaging
VDP with FEV1, although the relationship between VDP and FEV1/FVC was
significantly stronger for 129Xe MR imaging (P = .01). There were also significant and similar correlations for 3He
and 129Xe MR imaging ADC and DLCO
(Table 3). Figure 3 shows the significant
and strong relationships for 3He and
129
Xe ADC with relative areas with attenuation values of less than 2950 HU
(r = 0.90, P = .0005) and areas with

radiology.rsna.org
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Figure 1

Figure 1: Static ventilation 3He and 129Xe MR images in three healthy volunteers and three patients with COPD. Images of the two coronal center sections, where trachea and two main bronchi are clearly visible, are registered to grayscale 1H MR images of thorax. Volunteer in S1 is 75-year-old woman with percentage predicted FEV1 of 93% and FEV1/FVC of 70%; volunteer in S2 is 57-year-old man with
percentage predicted FEV1 of 95% and FEV1/FVC of 72%; volunteer in S3 is 51-year-old man with percentage predicted FEV1 of 120%
and FEV1/FVC of 83%. Patient in S1 is 77-year-old woman with percentage predicted FEV1 of 50% and FEV1/FVC of 20%; patient in S2
is 68-year-old woman with percentage predicted FEV1 of 59% and FEV1/FVC of 53%; patient in S3 is 71-year-old man with percentage
predicted FEV1 of 107% and FEV1/FVC of 58%. 3He gas distribution is displayed in red and 129Xe gas distribution is displayed in purple.
Radiology: Volume 265: Number 2—November 2012
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Table 2
He and 129Xe MR Imaging Measurements

3

Healthy Volunteers (n = 8)
3

Parameter
Gas distribution (%)
VDP
Cluster 2
Cluster 3
Cluster 4
Cluster 5
ADC (cm2/sec)

He MR Imaging*

4 (2)
10 (1)
36 (5)
34 (2)
16 (5)
0.246 (.021)

Patients with COPD (n = 10)

129

P Value†

3

129

P Value†

4 (4)
11 (5)
26 (10)
40 (2)
19 (3)
0.053 (.002) ‡

.56 (.99)
.94 (.94)
.08 (.48)
.008 (.06)
.22 (.99)
.002 (.02)

20 (10)
14 (2)
34 (5)
23 (7)
10 (4)
0.481 (.121)

34 (13)
15 (3)
22 (6)
20 (9)
9 (4)
0.079 (.015)

.003 (.03)
.30 (.99)
.002 (.002)
.05 (.35)
.50 (.99)
,.0001 (.001)

Xe MR Imaging*

He MR Imaging*

Xe MR Imaging*

* Numbers in parentheses are standard deviations.
†

Significant difference between groups (P , .05) was determined by using a two-tailed Wilcoxon signed rank test for gas distribution measurements and a two-tailed paired t test for ADC
measurements. Numbers in parentheses are Holm-Bonferroni–adjusted P values.

‡

Available for three subjects.

Figure 2

Figure 2: Graphs show relationship between VDP and ADC obtained at 3He and 129 Xe MR imaging. A, 3He VDP shows
significant and positive correlation with 129Xe VDP (r = 0.91, P , .0001; r 2 = 0.82, P , .0001; y = 1.4 3 +2.7). Dashed lines
= 95% confidence intervals of regression line. B, Mean bias (6standard deviation) between 3He and 129Xe VDP is 29% 6 8
(lower limit = 225%, upper limit = 7%). Solid line = mean difference, dashed lines = 95% limits of agreement. C, 3He ADC
shows significant and positive correlation with 129Xe ADC (r = 0.97, P , .0001; r2 = 0.93, P , .0001; y = 0.11 3 +0.03).
Dashed lines = 95% confidence intervals of regression line.

attenuation values in the 15th percentile (r = 20.91, P = .0003) for patients
with COPD only.
Theoretical diffusion coefficients
were generated as previously described
(42) for 3He-N2 and 129Xe-4He and are
summarized in Table E1 (online). The
3
He-N2 diffusion coefficient in air for
3
He-N2 was 0.826 cm2/sec, whereas the
diffusion coefficient in air for 129Xe-4He
was 0.211 cm2/sec and the self-diffusion
coefficient of air was 0.218 cm2/sec.

Discussion
We evaluated 3He and 129Xe MR images acquired within approximately 5
606

minutes in healthy subjects and in patients with COPD and made the following observations: (a) significant and
strong correlations were observed between VDPs obtained at 3He and 129Xe
MR imaging, although visually and quantitatively VDPs obtained with 129Xe MR
imaging were worse than those obtained
with 3He MR imaging in patients with
COPD but not in healthy subjects; (b)
significant and strong correlations were
observed that were similar for 3He and
129
Xe VDPs with FEV1 but significantly
stronger between 129Xe VDP and FEV1/
FVC; and (c) a significant and strong
correlation was observed between
ADCs obtained with 3He and 129Xe, both

of which showed similar and significant
correlations with DLCO and CT measurements of emphysema.
First, in patients with COPD, the
gas distribution at 129Xe MR imaging
was qualitatively more regionally heterogeneous than that at 3He MR imaging. This was not the case in healthy
volunteers, where 129Xe and 3He MR
imaging showed homogeneous gas
distribution and very low VDPs that
were not significantly different. The
visually obvious differences between
129
Xe and 3He were also quantitatively
different, with 129Xe VDP significantly
greater (worse) than 3He VDP in patients with COPD but not in healthy
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Table 3
Relationships between 3He and 129Xe MR Imaging Parameters and Pulmonary Function Measurements
Pulmonary Function
Measurement
FEV1*
FEV1/FVC
DLCO*

3

129

He MR Imaging

Xe MR Imaging

VDP (%)

ADC (cm2/sec)

VDP (%)

ADC (cm2/sec)

20.84 (,.0001) [,.0001]
20.84 (,.0001) [.001]†
20.83 (.0001) [.001]‡

20.75 (.0007) [.002]
20.86 (,.0001) [.001]
20.95 (,.0001) [.001]§

20.89 (,.0001) [.001]
20.95 (.0001) [.001]†
20.92 (,.0001) [.001]‡

20.67 (0.01) [.01]
20.77 (.002) [.004]
20.93 (,.0001) [.001]||

Note.—Data are Pearson correlation coefficients. Numbers in parentheses are P values. Numbers in brackets are Holm-Bonferroni–adjusted P values. Significant difference (P , .05) between 3He and
129
Xe MR imaging correlation coefficients for each r value was calculated by using the Fisher z9 transformation.
* Data are percentage predicted values.
†

The relationship between VDP and FEV1/FVC was significantly stronger for 129Xe imaging (P = .01).

‡

Available for 15 subjects.

§

Available for 13 subjects.

||

Available for 10 subjects.

Figure 3

Figure 3: Graphs show relationships between ADCs obtained with 3He and 129Xe MR imaging and CT
measurements. A, Areas with attenuation values in the 15th percentile (HU15) at CT show significant
correlation with 3He ADC (r = 20.91, P = .0003; r 2 = 0.83, P = .0003; y = 2225 3 2839) and 129Xe
ADC (r = 20.91, P = .0003; r 2 = 0.82, P = .0003; y = 21815 3 2803). B, Relative areas with attenuation values of less than 2950 HU at CT (RA950) show significant correlation with 3He ADC (r = 0.90,
P = .0005; r 2 = 0.80, P = .0005; y = 105 3 232) and 129Xe ADC (r = 0.87, P = .001; r 2 = 0.76, P =
.001; y = 821 3 247). Dashed lines = 95% confidence intervals of regression line.
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volunteers. Importantly, these differences could not be attributed to differences in the pulse sequences used, nor
was there a bias detected for specific
anterior-posterior sections dominating
this result. This unexpected result leads
to the simple question: Why are these
measurements different in COPD?
Some explanations might derive from
the different gases themselves. In
COPD, significant airflow limitation
is thought to occur in small conducting airways less than 2 mm in diameter (56), increasing airway resistance
with the potential for regional and
preferential 129Xe gas limitation to the
distal airways. Another important consideration relates to the terminal and
respiratory bronchioles, where diffusion dominates, and the lower diffusion
coefficient of 129Xe relative to 3He may
result in slower gas movement into the
distal diseased lung regions. Another
important consideration is the role of
collateral ventilation in COPD. The
lower atomic mass and higher diffusivity of 3He relative to 129Xe may allow for
regions of lung that are not ventilated
to gradually fill with 3He over the time
course of breath-hold imaging, as has
been shown recently by Marshall et al
(57). Our finding that VDP was greater
for 129Xe MR imaging than for 3He MR
imaging, with both 3D and 2D image
acquisition, suggests that the lower diffusivity of 129Xe may slow the process
of delayed and/or collateral ventilation
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beyond a realistic single-breath-hold
time. To try to better understand the
properties of the two gases inhaled, we
generated theoretical diffusion coefficients as previously described (42) for
3
He diluted with N2 and air and 129Xe
diluted with 4He and air and compared
these to the theoretical self-diffusion
coefficient of air. Taken together, these
results indicated that air has a similar
estimated diffusion coefficient as 129Xe
diluted with 4He and air (within 3%)
and that both diffusion coefficients are
much lower than the estimated diffusion coefficient of 3He diluted with N2
and air. Although the exact etiology
that may explain the differences between the gas distributions at 129Xe
and 3He MR imaging in COPD has not
yet been established, it is possible that
the differences in diffusion coefficients
might provide part of the reason for
these observed differences and that
different gas mixtures may be helpful
in probing different airway and parenchymal abnormalities. For example, the
larger 129Xe VDP in COPD might reflect
the fact that airway narrowing is less
easily penetrated by 129Xe-4He.
Second, we reported significant and
similar correlations between 3He and
129
Xe VDP and spirometric measurements for all subjects; however, the
correlation coefficient was significantly
stronger between 129Xe VDP and FEV1/
FVC. We note that, during expiration in
COPD, airway narrowing is caused by a
combination of many factors, including
small-airway wall thickening and obliteration and collapse of airways secondary to the loss of lung tissue within the
lungs. FEV1/FVC is reduced in subjects
with severe COPD and asthma and has
been reported to be sensitive to airway
narrowing and bronchoconstriction
(58). The finding that the correlation
of VDP with FEV1/FVC was stronger
with 129Xe than with 3He lends support
to the notion that the differences in the
diffusion coefficients of the gases might
be helpful in probing different airway
and parenchymal abnormalities.
Finally, we also reported strong and
significant correlations between 3He and
129
Xe ADCs in the same subjects and
similar correlation coefficients between
608

3

Kirby et al

He and 129Xe ADCs and DLCO and CT
measurements. The relationship between 129Xe ADC and spirometric measurements for b = 12 sec/cm2 has been
previously reported (39) in patients
with COPD and healthy volunteers, and
similar correlation coefficients for the
percentage predicted FEV1 and FEV1/
FVC were observed herein. However,
we reported slightly higher ADCs for
both healthy volunteers and ex-smokers
with COPD, and this may be due to the
differences in the inspired gas mixtures
between the two different studies. We
note that a 1.0-L 129Xe dose was used
in the previously published study and,
as shown in Table E1 (online), the estimated diffusion coefficient of 129Xe in
air was 0.138 cm2/sec whereas that of
129
Xe diluted with 4H and air as used
in this study was 0.211 cm2/sec. In addition, the strong correlations between
129
Xe with 3He ADC and the strong and
similar correlations between both 129Xe
and 3He ADC with CT measurements
of emphysema suggest that 129Xe DW
imaging with b = 12 sec/cm2 is sensitive
to lung microstructural abnormalities.
The comparable results we observed
with 3He and 129Xe ADCs suggest that
both methods are probing similar spatial dimensions, which is important because the choice of DW gradient can
influence the measured ADC. We must
also note that the patients with COPD
investigated herein showed varying degrees of emphysema, with percentage
predicted DLCO values ranging from
17% to 67%, indicating that 129Xe MR
imaging as used in this study provided
a way to measure varying degrees of
emphysema. Future studies comparing
129
Xe ADC with different b values to
3
He ADC and CT emphysema measurements, as well as comparing the 129Xe
ADC anterior-posterior gradients with
different b values, which has been previously shown by using 3He MR imaging
to change following treatment in COPD
(36), are required to determine the differences that DW provides for probing
the lung microstructure.
We recognize that this work was
limited by the small number of subjects and the fact that the analysis
was restricted mainly to patients with

moderate-to-severe COPD. Therefore,
caution should be exercised in extrapolating these results to the general
COPD population and, more specifically, patients with mild and very severe
disease. We must also acknowledge
that because all of these measurements
and tests were performed in the same
small subject group, extrapolation of
these results to a general COPD population cannot be confirmed until studies
with larger sample sizes are performed.
Another limitation is the difference in
pulse sequences used for 3He and 129Xe
MR imaging. However, results obtained
with non-DW images acquired with 2D
fast gradient-recalled echo sequences
were in agreement with those from
2D 3He and 3D 129Xe MR imaging, indicating that there was no difference
between 3He and 129Xe VDPs for the
healthy volunteers. For patients with
COPD, however, 129Xe VDP was greater
than 3He VDP.
In summary, there was a strong
correlation between 129Xe and 3He
ADCs in healthy volunteers and patients with COPD but significant differences in 129Xe and 3He gas distribution
in COPD, reflecting differences in the
gases as well as physiologic and/or anatomic abnormalities in COPD not seen
in healthy volunteers.
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